Literature DB >> 8739396

Inflammatory mechanisms in Alzheimer's disease.

M Hüll1, S Strauss, M Berger, B Volk, J Bauer.   

Abstract

In recent years many studies have indicated an involvement of inflammatory mechanisms in Alzheimer's disease (AD). Acute-phase proteins such as alpha 1-antichymotrypsin and c-reactive protein, elements of the complement system, and activated microglial and astroglial cells are consistently found in brains of AD patients. Most importantly, also cytokines such as interleukin-6 (IL-6) have been detected in the cortices of AD patients, indicating a local activation of components of the unspecific inflammatory system. Up to now it has remained unclear whether inflammatory mechanisms represent a primary event or only an unspecific reaction to brain tissue damage. Therefore, we investigated whether IL-6 immunoreactivity could be found in plaques prior to the onset of neuritic changes, or whether the presence of this cytokine is restricted to later stages of plaque pathology. We confirmed our previous observation that IL-6 is detectable in a significant proportion of plaques in the brains of demented patients. In AD patients IL-6 was found in diffuse plaques in a significant higher ratio as would have been expected from a random distribution of IL-6 among all plaque types. This observation suggests that IL-6 may precede neuritic changes, and that immunological mechanism may be involved both in the transformation from diffuse to neuritic plaques in AD and in the development of dementia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739396     DOI: 10.1007/bf02189112

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  35 in total

1.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

2.  Diagnosis of Alzheimer's disease.

Authors:  Z S Khachaturian
Journal:  Arch Neurol       Date:  1985-11

3.  Cerebrospinal fluid interleukin-6 activity in HIV infection and inflammatory and noninflammatory diseases of the nervous system.

Authors:  M A Laurenzi; A Sidén; M A Persson; G Norkrans; L Hagberg; F Chiodi
Journal:  Clin Immunol Immunopathol       Date:  1990-11

Review 4.  Interleukin-6 and its receptor during homeostasis, inflammation, and tumor growth.

Authors:  J Bauer
Journal:  Klin Wochenschr       Date:  1989-07-17

5.  Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices.

Authors:  J Bauer; S Strauss; U Schreiter-Gasser; U Ganter; P Schlegel; I Witt; B Yolk; M Berger
Journal:  FEBS Lett       Date:  1991-07-08       Impact factor: 4.124

6.  Effects of kainic acid on messenger RNA levels of IL-1 beta, IL-6, TNF alpha and LIF in the rat brain.

Authors:  M Minami; Y Kuraishi; M Satoh
Journal:  Biochem Biophys Res Commun       Date:  1991-04-30       Impact factor: 3.575

7.  Temporal sequence of plaque formation in the cerebral cortex of non-demented individuals.

Authors:  D L Sparks; H Liu; S W Scheff; C M Coyne; J C Hunsaker
Journal:  J Neuropathol Exp Neurol       Date:  1993-03       Impact factor: 3.685

8.  Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP).

Authors:  P E Gottschall; I Tatsuno; A Arimura
Journal:  Brain Res       Date:  1994-02-21       Impact factor: 3.252

Review 9.  Microglia in degenerative neurological disease.

Authors:  P L McGeer; T Kawamata; D G Walker; H Akiyama; I Tooyama; E G McGeer
Journal:  Glia       Date:  1993-01       Impact factor: 7.452

10.  Interleukin-6 and selected plasma proteins in healthy persons of different ages.

Authors:  K Hager; U Machein; S Krieger; D Platt; G Seefried; J Bauer
Journal:  Neurobiol Aging       Date:  1994 Nov-Dec       Impact factor: 4.673

View more
  13 in total

1.  C/T conversion alters interleukin-1A promoter function in a human astrocyte cell line.

Authors:  Xing Wei; Xianming Chen; Christine Fontanilla; Liming Zhao; Zhong Liang; Richard Dodel; Hampel Hampel; Martin Farlow; Yansheng Du
Journal:  Life Sci       Date:  2006-12-23       Impact factor: 5.037

Review 2.  Interleukin 6 and cognitive dysfunction.

Authors:  Isabel Trapero; Omar Cauli
Journal:  Metab Brain Dis       Date:  2014-04-30       Impact factor: 3.584

3.  Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6.

Authors:  T E Nelson; A Olde Engberink; R Hernandez; A Puro; S Huitron-Resendiz; C Hao; P N E De Graan; D L Gruol
Journal:  Brain Behav Immun       Date:  2012-05-17       Impact factor: 7.217

4.  Chronic alcohol-induced liver injury correlates with memory deficits: Role for neuroinflammation.

Authors:  Jean A King; Benjamin C Nephew; Asmita Choudhury; Guillaume L Poirier; Arlene Lim; Pranoti Mandrekar
Journal:  Alcohol       Date:  2019-08-06       Impact factor: 2.405

Review 5.  Physiological and pathological roles of interleukin-6 in the central nervous system.

Authors:  D L Gruol; T E Nelson
Journal:  Mol Neurobiol       Date:  1997-12       Impact factor: 5.590

6.  Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain.

Authors:  Harald Hampel; Andreas Haslinger; Michael Scheloske; Frank Padberg; Petra Fischer; Josef Unger; Stefan Johannes Teipel; Michaela Neumann; Carlyn Rosenberg; Rusti Oshida; Christine Hulette; Dieter Pongratz; Michael Ewers; H A Kretzschmar; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-11-26       Impact factor: 5.270

Review 7.  CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

Authors:  Nancy Bartolotti; Orly Lazarov
Journal:  Brain Behav Immun       Date:  2019-01-12       Impact factor: 7.217

Review 8.  Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease.

Authors:  Matthew J Bellizzi; Shao-Ming Lu; Harris A Gelbard
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

9.  Sarcopenia and impairment in cognitive and physical performance.

Authors:  Magdalena I Tolea; James E Galvin
Journal:  Clin Interv Aging       Date:  2015-03-30       Impact factor: 4.458

10.  Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study.

Authors:  Soo Chan Carusone; Marek Smieja; William Molloy; Charlie H Goldsmith; Jim Mahony; Max Chernesky; Judy Gnarpe; Tim Standish; Stephanie Smith; Mark Loeb
Journal:  BMC Neurol       Date:  2004-10-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.